# CHBNCT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chbnct

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Total disclosed funding: $14M
- Latest round: Angel (Aug 2, 2023)
- Investors on record: 4

## About

Based in Hangzhou, China, and established in 2023, CHBNCT is a medical equipment company that provides boron neutron capture therapy (BNCT) devices for cancer. Professor Sheng Wang, the company's founder, an internationally renowned neutron scientist, and established Advanced Neutron Technology Lab in Xi'an Jiaotong University in 2015. In August 2025, CHBNCT raised a series Pre-A funding co-led by new investors Hongcheng Investment Management, Hangzhou Huadian Investment Management Co., Ltd., Taizhou Circular Economy, Zhejiang Stock Hangzhou Capital and returning investor Kaitai Capital with participation from new investors Huzhou Industrial Investment Development Group Co., Ltd., Safe & Rich Venture Capital and Caitong Capital.  The company provides boron neutron capture therapy devices for cancer. The devices use thermal neutrons to react with element 10B in the boron drug at the tumour site in a capture reaction to generate alpha particles and 7Li nuclei, and then precisely killing tumour cells. Compared with conventional radiotherapy, proton, heavy ion and other radiotherapy techniques, BNCT has the advantages of shorter treatment time, targeting, fewer side effects, and controllable cost. The company generates revenue through providing boron neutron capture therapy devices. This company will accelerate the clinical application and industrialization of BNCT technology.

## Funding rounds

- Angel, Aug 2, 2023, $14M — Kaitai Capital, Casstar Capital, Shanhai Capital, Nuoyu Capital

## Investors

- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Angel
- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Angel
- Shanhai Capital (https://capitalatlas.ai/funds/shanhai-capital) — Angel
- Nuoyu Capital — Angel